3.4.22.B26: calpain 6
This is an abbreviated version!
For detailed information about calpain 6, go to the full flat file.
Word Map on EC 3.4.22.B26
-
3.4.22.B26
-
non-proteolytic
-
medicine
-
myometrium
-
leiomyomas
-
nonlysosomal
-
pinocytotic
-
calpastatin
- 3.4.22.B26
-
non-proteolytic
- medicine
-
myometrium
- leiomyomas
-
nonlysosomal
-
pinocytotic
- calpastatin
Reaction
A microtubule-stabilizing protein. The enzyme lacks the active-site catalytic cysteine residue and proteolytic activity has not been detected. =
Synonyms
calpain 6, calpain-6, CAPN6
ECTree
Advanced search results
Results | in table |
---|---|
2 | AA Sequence |
4 | Application |
141 | Disease/ Diagnostics |
4 | Expression |
9 | General Information |
2 | Inhibitors |
6 | Organism |
1 | Reaction |
6 | Reference |
18 | Source Tissue |
4 | Synonyms |
Expression
Expression on EC 3.4.22.B26 - calpain 6
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
calpain-6 expression depends on NFkappaB activity and endothelin-1. Calpain-6 expression is increased by doxorubicin
-
calpain-6 expression in osteosarcoma cells depends on endothelin-1. Calpain-6 is increased by doxorubicin (10 ng/ml) and expressed at higher levels in doxorubicin-resistant U2OS osteosarcoma-derived cells as compared to responsive cells
-
calpain-6 is a target gene downregulated by syndecan-2 in cells and in vivo. Syndecan-2 decreases calpain-6 expression by inhibiting endothelin-1-induced signaling
-
calpain-6 mRNA and CAPN6 protein levels are down-regulated by 10% fetal calf serum
-